AFX Carl Zeiss Meditec AG

Carl Zeiss Meditec has seen its share price fall sharply in recent years, which puts the spotlight firmly on whether the current valuation is still supported by its earnings. For anyone following the stock, the key issue now is how much of that setback is already reflected in what the market is willing to pay for each euro of profit. The share price has declined 80.6% over the past 5 years, which raises the question of how investors are now weighing the business against its earnings...

Carl Zeiss Meditec (XTRA:AFX) heads into the Berenberg and Goldman Sachs 15th German Corporate Conference on 23 September with investors watching how management frames recent share performance and underlying medical technology trends. Carl Zeiss Meditec’s share price has slipped over recent months, with a 30 day share price return of down 9.11% and a year to date share price return of down 25.49%. The 1 year total shareholder return of down 34.30% points to longer running pressure on...